ABVC — ABVC Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for ABVC Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-Q	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.27	5.94	0.161	0.139	0.313
Net Total Accounts Receivable
Net Total Receivables	0.999	1.71	1.37	0.76	1.16
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6.17	9.63	2.99	1.66	2.18
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.29	2	1.74	1.38	1.15
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11.6	13.7	9.58	7.78	7.54
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.84	3.69	5.54	6.1	6.56
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	8.17	4.85	6.48	6.23	6.31
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	3.44	8.84	3.1	1.55	1.23
Total Liabilities & Shareholders' Equity	11.6	13.7	9.58	7.78	7.54
Total Common Shares Outstanding